Researchers in England say they have the first evidence that a drug can improve COVID-19 survival: A cheap, widely available steroid reduced deaths by up to one third in severely ill hospitalized patients.
Jun 16, 2020
1
1048
Early data from a clinical study suggest that blocking the Bruton tyrosine kinase (BTK) protein provided clinical benefit to a small group of patients with severe COVID-19. Researchers observed that the off-label use of the ...
Jun 5, 2020
1
279
(HealthDay)—There seems to be no significant difference between a five- and 10-day course of remdesivir for patients with severe COVID-19 not requiring mechanical ventilation, according to a study published online May 27 ...
May 29, 2020
0
5
Anti-viral drug remdesivir cuts recovery times in coronavirus patients, according to the full results of a trial published Friday night, three weeks after America's top infectious diseases expert said the study showed the ...
May 23, 2020
5
959
Blood biomarkers that reflect the body's response to infection—including white blood cell count, absolute neutrophil count, C-reactive protein (CRP) and procalcitonin—are generally not useful in predicting the overall ...
May 13, 2020
0
2
A randomized, controlled clinical trial evaluating the safety and efficacy of a treatment regimen of the investigational antiviral remdesivir plus the anti-inflammatory drug baricitinib for coronavirus disease 2019 (COVID-19) ...
May 8, 2020
0
31
(HealthDay)—A new analysis suggests there may be a simple, noninvasive technique that could delay, or even eliminate, the need for ventilation in COVID-19 patients.
May 6, 2020
0
21
As researchers try to find treatments and create a vaccine for COVID-19, doctors and others on the front lines continue to find perplexing symptoms. And the disease itself has unpredictable effects on various people. Dr. ...
May 6, 2020
0
0
A study reported in the journal Cell Metabolism on April 30 adds to the evidence that people with type 2 diabetes (T2D) are at greater risk of a poor outcome should they become infected with the virus that causes COVID-19. ...
May 1, 2020
0
6
Montefiore Health System, Albert Einstein College of Medicine and NYU Langone have launched a new clinical trial to study if convalescent plasma—taken from people who have recovered from COVID-19—is effective in treating ...
Apr 29, 2020
0
0
